BRIEF published on 05/13/2026 at 07:48, 11 days 1 hour ago Rapport de performance financière de Dermapharm Holding SE pour le premier trimestre 2026 Résultats Financiers Acquisitions Croissance Des Revenus Médicaments De Marque Confirmation Des Directives
BRIEF published on 05/13/2026 at 07:48, 11 days 1 hour ago Dermapharm Holding SE Q1 2026 Financial Performance Report Financial Results Revenue Growth Acquisitions Guidance Confirmation Branded Pharmaceuticals
PRESS RELEASE published on 05/13/2026 at 07:43, 11 days 1 hour ago Dermapharm Holding SE performs in line with projections in Q1 2026 and confirms guidance Dermapharm Holding SE reports Q1 2026 results: 1.1% revenue growth to EUR 305.8 million, EBITDA up 7.5% to EUR 87.4 million. Confirms guidance for 2026 EBITDA Revenue Growth Dermapharm Holding SE Q1 2026 2026 Guidance
BRIEF published on 03/31/2026 at 07:35, 1 month 24 days ago Dermapharm Holding SE prévoit des résultats financiers mitigés en 2025 Baisse Des Revenus Augmentation De L'EBITDA Croissance Des Produits Pharmaceutiques De Marque Stabilité Des Produits De Santé Dépôt D'importation Parallèle
BRIEF published on 03/31/2026 at 07:35, 1 month 24 days ago Dermapharm Holding SE sees mixed financial outcomes in 2025 Revenue Decline EBITDA Increase Branded Pharmaceuticals Growth Healthcare Products Stability Parallel Import Drop
PRESS RELEASE published on 03/31/2026 at 07:30, 1 month 24 days ago Dermapharm Holding SE reports dip in revenue, rise in adjusted consolidated EBITDA and margin Dermapharm Holding SE reports dip in revenue but rise in adjusted consolidated EBITDA and margin for the 2025 financial year, with expectations of further growth in 2026 Adjusted EBITDA Dermapharm Holding SE Revenue Dip Financial Year 2025 Margin Rise
BRIEF published on 03/26/2026 at 20:53, 1 month 28 days ago Dermapharm Executes Share Buyback Amid Strong Interest Share Buyback Financial Management Treasury Shares Stock Market Dermapharm
BRIEF published on 03/26/2026 at 20:53, 1 month 28 days ago Dermapharm procède à un rachat d'actions face à un fort intérêt Rachat D'actions Marché Boursier Gestion Financière Dermapharm Actions Du Trésor
PRESS RELEASE published on 03/26/2026 at 20:48, 1 month 28 days ago Dermapharm Holding SE repurchases 4,299,190 shares under its public share buyback offer Dermapharm Holding SE repurchases 4,299,190 shares under its public share buyback offer. Company's buyback program exceeded maximum shares tendered. Offer price to be available by 2 April 2026 Share Buyback Treasury Shares Public Offer Dermapharm Holding SE Stock Repurchase
BRIEF published on 03/10/2026 at 09:16, 2 months 13 days ago Dermapharm Holding SE Announces Share Buyback Offer Share Buyback Dermapharm Holding SE Capital Measures 4,300,000 Shares EUR 42.00 Per Share
Published on 05/23/2026 at 19:45, 13 hours 29 minutes ago Golden Minerals Announces Closing of Equity Financing
Published on 05/23/2026 at 03:15, 1 day 5 hours ago UraniumX Approved for Trading on the OTCQB Venture Market and Announces Board Change
Published on 05/23/2026 at 03:00, 1 day 6 hours ago Battery X Metals Reports Up to ~84 km Estimated Driving Range Increase Across Multiple BYD Electric Vehicles Following Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Trials, Demonstrating Performance Improvement Across the World’s Larges
Published on 05/23/2026 at 02:25, 1 day 6 hours ago Battery X Metals Announces up to $2 Million Private Placement Financing and Initiative to Strengthen Balance Sheet
Published on 05/23/2026 at 02:25, 1 day 6 hours ago Bolt Metals Completes 402 line-km MobileMT Survey at Northwind Property, Quebec
Published on 05/24/2026 at 05:55, 3 hours 18 minutes ago The 26th CIFIT to Open in Xiamen This September, Preceded by Successful Guangzhou Roadshow
Published on 05/24/2026 at 05:35, 3 hours 38 minutes ago CGTN: Xizang at 75: Development and culture create a 'miracle on Earth'
Published on 05/23/2026 at 16:30, 16 hours 43 minutes ago HiFS 2026: Upgrading Four Major Digital Finance Solutions to Accelerate Financial Institutions Toward Agentic Banking
Published on 05/23/2026 at 15:57, 17 hours 17 minutes ago EQS-Adhoc: Delivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
Published on 05/22/2026 at 22:05, 1 day 11 hours ago Abivax présente ses résultats financiers du T1 2026 et les données à trois ans de l’étude 108, un essai d’extension ouvert de phase 2a/2b évaluant l’obéfazimod après réduction de dose dans la RCH
Published on 05/22/2026 at 19:35, 1 day 13 hours ago PROJET D'EVOLUTION DE SA GOUVERNANCE ET LA NOMINATION D'UN PRESIDENT DU DIRECTOIRE PAR INTERIM
Published on 05/22/2026 at 18:05, 1 day 15 hours ago Déclaration hebdomadaire d'opérations effectuées du 18 au 22 mai 2026
Published on 05/22/2026 at 18:05, 1 day 15 hours ago Disclosure of transactions in own shares from May 18 to May 22, 2026
Published on 05/22/2026 at 12:52, 1 day 20 hours ago Communiqué du Conseil d’administration – Assemblée Générale du 22 mai 2026
Published on 05/22/2026 at 12:52, 1 day 20 hours ago Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026
